Our label-free technologies
As our label-free technologies perform drug-target MoA under physiological conditions and in human samples, the test compound preserves its original structure and the exact same molecular structure that would be used in therapy.
We provide unbiased information about your drug and its natural environment that helps you find:
- The extreme limits of the physiological process
- How the physiological process can be modulated
- Why the individual is responding to this compound at the molecular level
- A description of the pathophysiology of the disease
Preclinical stage
Identify the mode of action of your compound with our NPOT® technology
Read more
From preclinical to clinical stage
Adopt a robust solution that can ensure the success of your Phase II study and accompany you in achieving the success of your drug candidate in Phase III
Read more
Clinical stage
Identify a cohort of patients responding to your therapy with our PIMS® technology
Read more
